posted on 2025-10-03, 16:05authored byJun Shirakawa, Dario F. De Jesus, Takahiro Tsuno, Giorgio Basile, Ryota Inoue, Tomozumi Takatani, Akira Nishiyama, Erin R. Okawa, Tomohiko Tamura, Yasuo Terauchi, Rohit N. Kulkarni
<p dir="ltr">Insulin-like growth factor -2 receptor (IGF2R), also known as cation-independent mannose-6-phosphate receptor (CI-MPR), is localized in cytosolic vesicles and is unique in its ability to transport enzymes to the lysosome and to clear IGF2 from the cell surface by acting as a scavenger receptor. To evaluate the direct role of IGF2R in β-cell biology we undertook complementary <i>in vitro</i> knockdown and <i>in vivo</i> knockout approaches. A β-cell line with a stable knockdown of IGF2R (IGF2RKD), exhibited decreased glucose-induced insulin secretion, and enhanced cell proliferation. Tamoxifen-inducible β-cell-specific IGF2R knockout mice exhibited impaired glucose tolerance and blunted insulin secretion after high-fat diet-loading that was likely secondary to reduced β-cell mass due to attenuated proliferation. β-cells with IGF2RKD exhibited decreased autophagosomes following starvation, which was accompanied by a reduced expression of p62, LC3B, and ULK1. Aged mice also showed impaired autophagy in βIGF2R-deficient β-cells. Reduced IGF2R function and m<sup>6</sup>A methylation were observed in islets from both mouse and human type 2 diabetes. Taken together, these data point to IGF2R as an important regulator of insulin secretion, cell proliferation and autophagy in mammalian β-cells.</p>
Funding
J.S. acknowledges support from the JST FOREST Program (24012821), MEXT of Japan (a Grant-in-Aid for Scientific Research (B) 23H03324); the Japan IDDM network; the Takeda Science Foundation; the Uehara Memorial Foundation; the Naito Foundation; the Daiichi Sankyo Foundation of Life Science; the Chugai Foundation for Innovative Drug Discovery Science; and the Taiju Life Social Welfare Foundation. This research was also supported by MEXT Promotion of Distinctive Joint Research Center Program Grant Numbers JPMXP0618217493 and JPMXP0622717006 at the Advanced Medical Research Center, Yokohama City University. R.N.K. acknowledges support from the Diabetes Research and Wellness Foundation Endowed Chair, NIH grants R01 DK067536, RC2 DK 139552, and R01 DK105588.